Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Events entities : Exact sciences corporation save search
Exact Sciences to Participate in March 2024 Investor Conference
Published: 2024-02-26 (Crawled : 12:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.87%
H: 2.56%
C: 0.84%
conference sciences
Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials
Published: 2023-08-30 (Crawled : 14:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.24%
H: 0.87%
C: -0.12%
institute test cancer trials sciences
Exact Sciences to participate in June 2023 investor conferences
Published: 2023-06-01 (Crawled : 11:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.1%
H: 3.12%
C: 2.87%
sciences
Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week® Annual Meeting
Published: 2023-05-09 (Crawled : 12:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -2.04%
H: 6.0%
C: 5.73%
week disease cancer sciences meeting
Exact Sciences to participate in May 2023 investor conference
Published: 2023-05-01 (Crawled : 12:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: -0.58%
conference sciences
Exact Sciences to participate in March investor conferences - February 22, 2023
Published: 2023-02-22 (Crawled : 15:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.21%
H: 7.46%
C: 5.77%
sciences
Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients
Published: 2022-12-09 (Crawled : 16:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.57%
H: 2.84%
C: -2.41%
sciences breast therapy cancer
Exact Sciences to participate in November 2022 investor conferences
Published: 2022-11-01 (Crawled : 11:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 2.79%
H: 1.12%
C: -2.66%
sciences
Exact Sciences to participate in September 2022 investor conference
Published: 2022-09-01 (Crawled : 11:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -1.32%
H: 3.53%
C: 3.31%
sciences conference
Exact Sciences to participate in June 2022 investor conferences
Published: 2022-05-27 (Crawled : 11:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 3.86%
H: 6.51%
C: 6.49%
sciences
Exact Sciences to participate in May 2022 investor conference
Published: 2022-05-02 (Crawled : 11:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -6.05%
H: 5.65%
C: 5.47%
conference
Exact Sciences to participate in March 2022 investor conferences
Published: 2022-02-28 (Crawled : 12:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 4.53%
H: 1.44%
C: -0.84%
conference
Exact Sciences to participate in February 2022 investor conferences
Published: 2022-02-01 (Crawled : 12:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 9.89%
H: 1.62%
C: 0.27%
ces conference
Exact Sciences to participate in J.P. Morgan Healthcare Conference - Jan 03, 2022
Published: 2022-01-03 (Crawled : 12:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.0%
H: 6.22%
C: 4.74%
health thc conference j.p. morgan healthcare conference
New Data Presented at SABCS® 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making
Published: 2021-12-08 (Crawled : 19:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.36%
H: 4.27%
C: 3.11%
sabcs test
Exact Sciences to participate in November 2021 investor conferences
Published: 2021-11-01 (Crawled : 11:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -1.41%
H: 4.91%
C: 3.79%
conference
Exact Sciences to participate in June 2021 investor conferences
Published: 2021-05-24 (Crawled : 11:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 2.05%
H: 2.05%
C: 0.93%
conference
Modeling Data Showed Cologuard® Was Superior to Fecal Immunochemical Test (FIT) on Cost Effectiveness and Colorectal Cancer Incidence and Mortality
Published: 2021-05-21 (Crawled : 00:20) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.26%
H: 2.45%
C: 0.26%
test cancer colorectal cancer
Exact Sciences to participate in May 2021 investor conferences
Published: 2021-05-03 (Crawled : 11:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.55%
H: 0.0%
C: -4.24%
conference
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.